CXR, Geron Wrap Up Alliance to Develop hESC Hepatocytes for ADME/Tox Assays | GenomeWeb
CXR Biosciences and Geron this week said they have concluded a research collaboration that focused on developing human embryonic stem cell-derived hepatocytes for use in ADME/Tox assays.
The companies are betting that their alliance will lead to a more reliable alternative to immortalized hepatocyte lines or primary human hepatocytes, which could attract drug makers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.